Literature DB >> 29179576

Rates and Predictors of Conversion to Schizophrenia or Bipolar Disorder Following Substance-Induced Psychosis.

Marie Stefanie Kejser Starzer1, Merete Nordentoft1, Carsten Hjorthøj1.   

Abstract

OBJECTIVE: The authors investigated the rates of conversion to schizophrenia and bipolar disorder after a substance-induced psychosis, as well as risk factors for conversion.
METHOD: All patient information was extracted from the Danish Civil Registration System and the Psychiatric Central Research Register. The study population included all persons who received a diagnosis of substance-induced psychosis between 1994 and 2014 (N=6,788); patients were followed until first occurrence of schizophrenia or bipolar disorder or until death, emigration, or August 2014. The Kaplan-Meier method was used to obtain cumulative probabilities for the conversion from a substance-induced psychosis to schizophrenia or bipolar disorder. Cox proportional hazards regression models were used to calculate hazard ratios for all covariates.
RESULTS: Overall, 32.2% (95% CI=29.7-34.9) of patients with a substance-induced psychosis converted to either bipolar or schizophrenia-spectrum disorders. The highest conversion rate was found for cannabis-induced psychosis, with 47.4% (95% CI=42.7-52.3) converting to either schizophrenia or bipolar disorder. Young age was associated with a higher risk of converting to schizophrenia. Self-harm after a substance-induced psychosis was significantly linked to a higher risk of converting to both schizophrenia and bipolar disorder. Half the cases of conversion to schizophrenia occurred within 3.1 years after a substance-induced psychosis, and half the cases of conversion to bipolar disorder occurred within 4.4 years.
CONCLUSIONS: Substance-induced psychosis is strongly associated with the development of severe mental illness, and a long follow-up period is needed to identify the majority of cases.

Entities:  

Keywords:  Alcohol Abuse; Mood Disorders-Bipolar; Psychoactive Substance Use Disorder; Psychosis; Schizophrenia

Mesh:

Substances:

Year:  2017        PMID: 29179576     DOI: 10.1176/appi.ajp.2017.17020223

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  25 in total

1.  Management of psychosis in the context of cannabis use: Beyond the chicken or the egg question.

Authors:  Clairélaine Ouellet-Plamondon; Simon Dubreucq; Didier Jutras-Aswad
Journal:  Paediatr Child Health       Date:  2020-06-15       Impact factor: 2.253

Review 2.  Cannabis Legalization and College Mental Health.

Authors:  Ludmila De Faria; Lillian Mezey; Aaron Winkler
Journal:  Curr Psychiatry Rep       Date:  2021-03-03       Impact factor: 5.285

3.  Physicians Warn Cannabis Can Cause Serious Health Hazards.

Authors:  Eric A Voth
Journal:  Mo Med       Date:  2021 May-Jun

4.  Marijuana Legalization Will Cause Many Problems for Missouri Law Enforcement and Schools.

Authors:  David G Evans
Journal:  Mo Med       Date:  2019 May-Jun

5.  Psychosis-Relevant Effects of Intravenous Delta-9-Tetrahydrocannabinol: A Mega Analysis of Individual Participant-Data from Human Laboratory Studies.

Authors:  Suhas Ganesh; Jose Cortes-Briones; Mohini Ranganathan; Rajiv Radhakrishnan; Patrick D Skosnik; Deepak Cyril D'Souza
Journal:  Int J Neuropsychopharmacol       Date:  2020-12-03       Impact factor: 5.176

Review 6.  A Cannabinoid Hypothesis of Schizophrenia: Pathways to Psychosis.

Authors:  Rachel Little; Dale D'Mello
Journal:  Innov Clin Neurosci       Date:  2022 Jul-Sep

7.  The genome-wide risk alleles for psychiatric disorders at 3p21.1 show convergent effects on mRNA expression, cognitive function, and mushroom dendritic spine.

Authors:  Zhihui Yang; Danyang Zhou; Huijuan Li; Xin Cai; Weipeng Liu; Lu Wang; Hong Chang; Ming Li; Xiao Xiao
Journal:  Mol Psychiatry       Date:  2019-11-13       Impact factor: 15.992

Review 8.  Substance-induced Psychosis in Youth.

Authors:  David Beckmann; Kelsey Leigh Lowman; Jessica Nargiso; James McKowen; Lisa Watt; Amy M Yule
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2019-09-23

9.  Association of Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence With the Risk of Subsequent Psychotic Disorder: A Systematic Review and Meta-analysis.

Authors:  Mikaïl Nourredine; Adrien Gering; Pierre Fourneret; Benjamin Rolland; Bruno Falissard; Michel Cucherat; Marie-Maude Geoffray; Lucie Jurek
Journal:  JAMA Psychiatry       Date:  2021-05-01       Impact factor: 21.596

10.  Timing of cannabis exposure relative to prodrome and psychosis onset in a community-based first episode psychosis sample.

Authors:  Emily R Kline; Maria Ferrara; Fangyong Li; Deepak Cyril D'Souza; Matcheri Keshavan; Vinod H Srihari
Journal:  J Psychiatr Res       Date:  2022-01-16       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.